Zak Mir talks to Tim McCarthy, Chairman and CEO, Immupharma, about the recent fund raise, highlights of the company’s portfolio, and the main focus of its drug discovery and development strategy.
Author
Tim McCarthy, Chairman and CEO, Immupharma
Your stock market edge
Sign up to Zaks Stock Market News Email
